Filing Details
- Accession Number:
- 0000950170-23-067875
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-04 19:06:26
- Reporting Period:
- 2023-11-30
- Accepted Time:
- 2023-12-04 19:06:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1762303 | Avita Medical Inc. | RCEL | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1491140 | D David O'toole | 28159 Avenue Stanford Suite 220 - Avita Medical Valencia CA 91355 | Cfo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-11-30 | 1,034 | $9.06 | 16,034 | No | 4 | A | Direct | |
Common Stock | Acquisiton | 2023-12-01 | 500 | $10.68 | 16,534 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | P | Direct |
Footnotes
- These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on July 1, 2023 and ending on November 30, 2023 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Company's stock on November 30, 2023 (the purchase date of the offering period).